Stanford-India Biodesign was launched in 2007 as a first-of-its-kind collaboration between Stanford University, the All India Institute of Medical Sciences (AIIMS), and the Indian Institute of Technology (IIT) Delhi. The goal of the partnership was to identify and train a first generation of local innovation leaders in medical technology who, in turn, would help stimulate India’s nascent medtech industry.
Each year, four India fellows came to Stanford to spend six months working in multidisciplinary teams to learn and apply biodesign process to real-world healthcare projects identified in Stanford’s hospitals and clinics. The fellows would then return to Delhi to repeat the process, this time to address the unmet healthcare needs of Indian patients, physicians, and healthcare facilities, and to take their innovative solutions forward into patient care.
Over the program’s nine-year duration, Stanford-India Biodesign trained 32 innovators who developed 14 technologies and started 13 companies. With this successful track record, our Indian partners transitioned to independent status and the program is now known as the School of International Biodesign, based at AIIMS. Read about some of the inspiring innovators and novel technologies from the program in the stories below.
Rheumatic heart disease (RHD) starts in childhood as strep throat. If not properly treated, it can lead to debilitating heart damage and death. To increase awareness of the early symptoms of RHD and its consequences in India, three Stanford-India Biodesign Fellows teamed up with Edwards Lifesciences to produce a public service video.
For Amit Sharma, being an innovator is not about running with the pack, it’s about being brave enough to stand alone or alongside those who have been left behind.
For Avijit Bansal, being an innovator is not about taking the well-beaten path; it’s about reshaping humanity’s idea of what’s possible.
“Stanford-India Biodesign changed – and continues to change – the trajectory of medtech innovation in India.”– Krista Donaldson, CEO, D-Rev
“We are proud of what Stanford-India Biodesign has accomplished and are delighted that our curriculum continues to be a guiding light for India’s aspiring medtech innovators.”– Rajiv Doshi, Director, India Program, Stanford Biodesign